A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug ...

David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests ...

Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...

The tie-up, which will create a firm with a combined revenue of around $2bn, will add around 10 US-based partners to Herbert ...

Maohua Wang, head of the IP group at King & Wood Mallesons in China, explains how the firm’s Eversheds deal affected the IP ...

Strength at the Unified Patent Court was among the factors that drew a life sciences patent litigator to join McDermott Will ...